                               SEQUENCE LISTING	

<110> CENTRILLION TECHNOLOGY HOLDING CORPORATION
 
<120> NATIVE-EXTENSION PARALLEL SEQUENCING

<130> 38558-704.601

<140> PCT/US2011/053079
<141> 2011-09-23

<150> 61/385,947
<151> 2010-09-23

<150> 61/385,562
<151> 2010-09-23

<160> 7     

<170> PatentIn version 3.5

<210> 1
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 1
tgctgcctcc ctgaccctac                                                   20


<210> 2
<211> 11
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 2
acgacggagg g                                                            11


<210> 3
<211> 14
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 3
acgacggagg gact                                                         14


<210> 4
<211> 17
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 4
tgctgcctcc ctgaccc                                                      17


<210> 5
<211> 17
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 5
acgacggagg gactggg                                                      17


<210> 6
<211> 21
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 6
acgacgccgc cactagttcc c                                                 21


<210> 7
<211> 12
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 7
tttggccaaa aa                                                           12
